Medical News

RSS

Plans for Medicare, deficit reduction continue to be political flashpoints

President Barack Obama will welcome Democratic congressional leaders to the White House this week to discuss the continuing budget debate.

11 May 2011

Mitt Romney to give 'big' health care speech

The address, which will be given in Michigan on Thursday, is seen as the GOP presidential hopeful's effort to confront what is seen as his key vulnerability - health reform. It will include his own plan to replace the new health law with more targeted changes that give states more responsibility in caring for the poor, elderly and ill.

11 May 2011

Analysis: Ryan's GOP budget plan would cause deep reductions in Medicaid coverage

The analysis, advanced by the Kaiser Family Foundation and the Urban Institute, could lead to as many as 44 million people being cut from the rolls in the next decade. Meanwhile, Politico reports that, in the background, some states are fast-tracking their efforts to expand coverage — in keeping with the requirements of the health law.

11 May 2011

Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency

Scientists at the University of Granada have confirmed that injecting a local anesthetic or botulinum toxin (botox) into certain points named "trigger points" of the pericraneal and neck muscles reduce migraine frequency among migraine sufferers. University of Granada researchers have identified the location of these trigger points -which activation results in migraine- and their relationship with the duration and severity of this condition.

11 May 2011

SunLink Health Systems third quarter net earnings increases to $2,683,000

SunLink Health Systems, Inc. today announced earnings from continuing operations for its fiscal quarter ended March 31, 2011 of $2,515,000, or $0.31 per fully diluted share, compared to earnings from continuing operations of $469,000, or $0.06 per fully diluted share, for the comparable quarter ended March 31, 2010.

11 May 2011

MHI team uses cryoablation to successfully treat atrial fibrillation

The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.

From Medtronic 11 May 2011

Response Biomedical first quarter total revenues increase 59% to $2,470,560

Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470,560 compared to $1,549,479 for the same period last year.

11 May 2011

Catasys commences enrollment for integrated substance dependence program in Nevada

Catasys, Inc. announced today that it has launched and begun enrollment for its integrated substance dependence program, called OnTrak™, in Nevada.

11 May 2011

American Medical Alert first quarter net income increases 18% to $1,046,378

American Medical Alert Corp. a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter ended March 31, 2011, the

11 May 2011

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that it has advanced a second drug from its cardiometabolic program, SPC4955 into Phase 1 clinical trials, for the treatment of high cholesterol.

11 May 2011

Winner Medical second quarter net sales increase 27% to $33.2 million

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the second quarter ended March 31, 2011.

11 May 2011

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

11 May 2011

China Pharma first quarter revenue increases 20% to $18.1 million

China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the quarter ended March 31, 2011.

11 May 2011

First Edition: May 11, 2011

Reporting for Kaiser Health News, Hilary Abramson writes: "Now comes the hard part. California, which has had a long, sometimes-tortured history of trying to overhaul its health care markets, beat every other state last year when it passed a law creating a health insurance exchange - an online marketplace where millions of uninsured residents will be able to get insurance".

11 May 2011

SAFC, Oncolytics Biotech sign commercial supply agreement for REOLYSIN

Oncolytics Biotech Inc. today announced that it has entered into a commercial supply agreement with SAFC, a Division of Sigma-Aldrich Corporation, for the commercial manufacture of REOLYSIN, Oncolytics proprietary reovirus.

11 May 2011

AspirinWorks Test now available in greater Boston and surrounding area

A simple urine test that measures aspirin effect is now available in the greater Boston and surrounding area. The AspirinWorks Test is available to eastern Massachusetts and southern New Hampshire area doctors through Diagnostic Laboratory Medicine.

11 May 2011

New poll: Ontarians support more public investment in home and community support services

A new poll shows Ontarians support more public investment in home and community support services with six in ten (59%) agreeing new funding is better designated to these preventative care services rather than facilities and full-time nursing care.

11 May 2011

TSO3 first quarter revenue decreases to $136,628

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings, posted revenues of $136,628 for the first quarter of 2011 ending March 31, for the sale of supplies, accessories and service contracts for the first generation product.

11 May 2011

Two new policy briefs on California health reform law

According to two new policy briefs from the UCLA Center for Health Policy Research, the majority of state residents likely to be eligible for federally mandated health insurance coverage initiatives in California in 2014 are also those who may be least likely to excessively use costly health services: men, singles and those of working age.

11 May 2011

Baylor has now patented new polarimeter that could prove useful in pharmaceuticals

Two Baylor University chemistry professors have invented a new polarimeter, a basic scientific instrument used to measure and interpret the polarization of transverse waves, such as light waves, that could prove useful in determining the purity of pharmaceuticals. Baylor has now patented the device.

11 May 2011

Medical News

Plans for Medicare, deficit reduction continue to be political flashpoints

Mitt Romney to give 'big' health care speech

Analysis: Ryan's GOP budget plan would cause deep reductions in Medicaid coverage

Injecting botox in 'trigger points' of pericraneal and neck muscles reduces migraine frequency

SunLink Health Systems third quarter net earnings increases to $2,683,000

MHI team uses cryoablation to successfully treat atrial fibrillation

Response Biomedical first quarter total revenues increase 59% to $2,470,560

Catasys commences enrollment for integrated substance dependence program in Nevada

American Medical Alert first quarter net income increases 18% to $1,046,378

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Winner Medical second quarter net sales increase 27% to $33.2 million

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

China Pharma first quarter revenue increases 20% to $18.1 million

First Edition: May 11, 2011

SAFC, Oncolytics Biotech sign commercial supply agreement for REOLYSIN

AspirinWorks Test now available in greater Boston and surrounding area

New poll: Ontarians support more public investment in home and community support services

TSO3 first quarter revenue decreases to $136,628

Two new policy briefs on California health reform law

Baylor has now patented new polarimeter that could prove useful in pharmaceuticals

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News